Literature DB >> 27064001

Biochemical and cell biological assays to identify and characterize DNA helicase inhibitors.

Taraswi Banerjee1, Monika Aggarwal2, Joshua A Sommers1, Robert M Brosh3.   

Abstract

The growing number of DNA helicases implicated in hereditary disorders and cancer indicates that this particular class of enzymes plays key roles in genomic stability and cellular homeostasis. Indeed, a large body of work has provided molecular and cellular evidence that helicases act upon a variety of nucleic acid substrates and interact with numerous proteins to enact their functions in replication, DNA repair, recombination, and transcription. Understanding how helicases operate in unique and overlapping pathways is a great challenge to researchers. In this review, we describe a series of experimental approaches and methodologies to identify and characterize DNA helicase inhibitors which collectively provide an alternative and useful strategy to explore their biological significance in cell-based systems. These procedures were used in the discovery of biologically active compounds that inhibited the DNA unwinding function catalyzed by the human WRN helicase-nuclease defective in the premature aging disorder Werner syndrome. We describe in vitro and in vivo experimental approaches to characterize helicase inhibitors with WRN as the model, anticipating that these approaches may be extrapolated to other DNA helicases, particularly those implicated in DNA repair and/or the replication stress response. Published by Elsevier Inc.

Entities:  

Keywords:  Cancer therapy; DNA repair; Helicase; Inhibitor; Replication; Small molecule; Werner syndrome

Mesh:

Substances:

Year:  2016        PMID: 27064001      PMCID: PMC5035559          DOI: 10.1016/j.ymeth.2016.04.007

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  39 in total

1.  The Bloom's and Werner's syndrome proteins are DNA structure-specific helicases.

Authors:  P Mohaghegh; J K Karow; R M Brosh; V A Bohr; I D Hickson
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

2.  Biochemical characterization of the DNA substrate specificity of Werner syndrome helicase.

Authors:  Robert M Brosh; Juwaria Waheed; Joshua A Sommers
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

3.  Defective telomere lagging strand synthesis in cells lacking WRN helicase activity.

Authors:  Laure Crabbe; Ramiro E Verdun; Candy I Haggblom; Jan Karlseder
Journal:  Science       Date:  2004-12-10       Impact factor: 47.728

Review 4.  DNA helicases as targets for anti-cancer drugs.

Authors:  Sudha Sharma; Kevin M Doherty; Robert M Brosh
Journal:  Curr Med Chem Anticancer Agents       Date:  2005-05

5.  Human werner syndrome DNA helicase unwinds tetrahelical structures of the fragile X syndrome repeat sequence d(CGG)n.

Authors:  M Fry; L A Loeb
Journal:  J Biol Chem       Date:  1999-04-30       Impact factor: 5.157

6.  Thiazole orange as the fluorescent intercalator in a high resolution fid assay for determining DNA binding affinity and sequence selectivity of small molecules.

Authors:  D L Boger; W C Tse
Journal:  Bioorg Med Chem       Date:  2001-09       Impact factor: 3.641

7.  WRN helicase expression in Werner syndrome cell lines.

Authors:  M J Moser; A S Kamath-Loeb; J E Jacob; S E Bennett; J Oshima; R J Monnat
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

8.  The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair.

Authors:  Wojciech Niedzwiedz; Georgina Mosedale; Mark Johnson; Chong Yi Ong; Paul Pace; Ketan J Patel
Journal:  Mol Cell       Date:  2004-08-27       Impact factor: 17.970

9.  Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.

Authors:  Helen E Bryant; Niklas Schultz; Huw D Thomas; Kayan M Parker; Dan Flower; Elena Lopez; Suzanne Kyle; Mark Meuth; Nicola J Curtin; Thomas Helleday
Journal:  Nature       Date:  2005-04-14       Impact factor: 69.504

10.  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.

Authors:  Hannah Farmer; Nuala McCabe; Christopher J Lord; Andrew N J Tutt; Damian A Johnson; Tobias B Richardson; Manuela Santarosa; Krystyna J Dillon; Ian Hickson; Charlotte Knights; Niall M B Martin; Stephen P Jackson; Graeme C M Smith; Alan Ashworth
Journal:  Nature       Date:  2005-04-14       Impact factor: 69.504

View more
  8 in total

1.  WRN rescues replication forks compromised by a BRCA2 deficiency: Predictions for how inhibition of a helicase that suppresses premature aging tilts the balance to fork demise and chromosomal instability in cancer.

Authors:  Arindam Datta; Robert M Brosh
Journal:  Bioessays       Date:  2022-06-25       Impact factor: 4.653

2.  Special Methods collection on DNA helicases.

Authors:  Robert M Brosh
Journal:  Methods       Date:  2016-08-24       Impact factor: 3.608

Review 3.  Interactive Roles of DNA Helicases and Translocases with the Single-Stranded DNA Binding Protein RPA in Nucleic Acid Metabolism.

Authors:  Sanket Awate; Robert M Brosh
Journal:  Int J Mol Sci       Date:  2017-06-08       Impact factor: 5.923

Review 4.  SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets.

Authors:  Jayalakshmi Vallamkondu; Albin John; Willayat Yousuf Wani; Suguru Pathinti Ramadevi; Kishore Kumar Jella; P Hemachandra Reddy; Ramesh Kandimalla
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-06-27       Impact factor: 5.187

5.  A high-throughput screen to identify novel small molecule inhibitors of the Werner Syndrome Helicase-Nuclease (WRN).

Authors:  Joshua A Sommers; Tomasz Kulikowicz; Deborah L Croteau; Thomas Dexheimer; Dorjbal Dorjsuren; Ajit Jadhav; David J Maloney; Anton Simeonov; Vilhelm A Bohr; Robert M Brosh
Journal:  PLoS One       Date:  2019-01-09       Impact factor: 3.240

Review 6.  New Insights Into DNA Helicases as Druggable Targets for Cancer Therapy.

Authors:  Arindam Datta; Robert M Brosh
Journal:  Front Mol Biosci       Date:  2018-06-26

7.  Drug targets for corona virus: A systematic review.

Authors:  Manisha Prajapat; Phulen Sarma; Nishant Shekhar; Pramod Avti; Shweta Sinha; Hardeep Kaur; Subodh Kumar; Anusuya Bhattacharyya; Harish Kumar; Seema Bansal; Bikash Medhi
Journal:  Indian J Pharmacol       Date:  2020-03-11       Impact factor: 1.200

Review 8.  Inhibition of DNA Repair in Cancer Therapy: Toward a Multi-Target Approach.

Authors:  Samuele Lodovichi; Tiziana Cervelli; Achille Pellicioli; Alvaro Galli
Journal:  Int J Mol Sci       Date:  2020-09-12       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.